Biolaser ApS: Financial statements 2018
CVR: 21333271
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Biolaser ApS (CVR 21333271) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 287,866 and a net result of DKK 223,301 compared with DKK 91,592 the year before. That is an increase of 142.8% compared with the year before. Equity in the 2018 report amounted to DKK 872,204. The solvency ratio was 76.9%.
- Gross Profit
- DKK 287,866
- Profit/Loss
- DKK 223,301
- Equity
- DKK 872,204
- Total Assets
- DKK 1,134,007
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 288 t. | 223 t. | 872 t. | 0 |
| 2017 | - | 119 t. | 92 t. | 649 t. | - |
| 2016 | - | 456 t. | 356 t. | 557 t. | - |
| 2015 | - | 207 t. | 66 t. | 202 t. | - |
| 2014 | - | 11 t. | -8 t. | 136 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
Biolaser ApS has published its annual report for 2017. Gross profit came to DKK 118,584, and the net result was DKK 91,592.
About Biolaser ApS
Biolaser ApS is a Danish company of the type Anpartsselskab based in Fjerritslev, founded in 1998. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Caitanya Candradasa. The company is owned by Caitanya Candradasa. In 2025, the company reported a gross profit of DKK -133,181 and a net result of DKK -141,615 compared with DKK 82,521 the year before. Equity in the 2025 report amounted to DKK 685,450.